Sutro Biopharma (STRO) Tax Provisions (2022 - 2025)
Sutro Biopharma (STRO) reported Tax Provisions of -$88000.0 for Q4 2025, down 103.74% on a YoY basis from $2.4 million in Q4 2024, and down 388.89% sequentially from -$18000.0 in Q2 2025.
Sutro Biopharma (STRO) Tax Provisions (2022 - 2025) Analysis & Trends
Sutro Biopharma (STRO) has 4 years of Tax Provisions data on file, last reported at -$88000.0 in Q4 2025.
- For the quarter ending Q4 2025, Tax Provisions fell 103.74% year-over-year to -$88000.0; the trailing twelve-month figure through Dec 2025 stood at $2.2 million (down 87.63% YoY), and the FY2025 full-year result was -$99000.0, down 104.19% from the prior year.
- Tax Provisions slipped to -$88000.0 in Q4 2025, from -$18000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $15.8 million in Q4 2023 to a low of -$88000.0 in Q4 2025.
- A 4-year average of $2.6 million and a median of $395000.0 in 2023 frame the typical range for Tax Provisions.
- Across the five-year window, Tax Provisions sank 85.11% in 2024 and plunged 325.0% in 2025, its largest moves.
- Tracing STRO's Tax Provisions over 4 years: stood at $2.5 million in 2022, then jumped by 532.6% to $15.8 million in 2023, then slumped by 85.11% to $2.4 million in 2024, then sank by 103.74% to -$88000.0 in 2025.
- Business Quant data shows STRO's Tax Provisions at -$88000.0 in Q4 2025, -$18000.0 in Q2 2025, and $2.4 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Sutro Biopharma | 192.86 Mn | 51.43 Mn | - | -88,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -88,000.00 |
| Jun 30, 2025 | -18,000.00 |
| Dec 31, 2024 | 2.36 Mn |
| Jun 30, 2024 | 8,000.00 |
| Dec 31, 2023 | 15.82 Mn |
| Sep 30, 2023 | 1.84 Mn |
| Jun 30, 2023 | 151,000.00 |
| Mar 31, 2023 | 395,000.00 |
| Jun 30, 2022 | 2.50 Mn |